Archford Capital Strategies’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$431K Sell
1,109
-312
-22% -$121K 0.06% 237
2025
Q1
$618K Sell
1,421
-2,538
-64% -$1.1M 0.09% 187
2024
Q4
$1.46M Buy
3,959
+487
+14% +$180K 0.22% 108
2024
Q3
$1.77M Buy
3,472
+117
+3% +$59.6K 0.27% 94
2024
Q2
$1.82M Buy
3,355
+75
+2% +$40.6K 0.29% 83
2024
Q1
$1.7M Sell
3,280
-2
-0.1% -$1.04K 0.29% 91
2023
Q4
$1.55M Sell
3,282
-153
-4% -$72.1K 0.28% 93
2023
Q3
$1.5M Sell
3,435
-75
-2% -$32.7K 0.3% 83
2023
Q2
$1.65M Sell
3,510
-44
-1% -$20.7K 0.31% 75
2023
Q1
$1.72M Sell
3,554
-1
-0% -$485 0.36% 65
2022
Q4
$1.82M Buy
3,555
+67
+2% +$34.4K 0.42% 59
2022
Q3
$1.58M Buy
3,488
+44
+1% +$20K 0.41% 60
2022
Q2
$1.66M Buy
3,444
+70
+2% +$33.8K 0.42% 58
2022
Q1
$1.67M Buy
3,374
+173
+5% +$85.6K 0.37% 69
2021
Q4
$1.48M Sell
3,201
-47
-1% -$21.8K 0.34% 75
2021
Q3
$1.21M Buy
3,248
+76
+2% +$28.3K 0.29% 91
2021
Q2
$1.21M Sell
3,172
-301
-9% -$115K 0.3% 83
2021
Q1
$1.29M Buy
3,473
+46
+1% +$17.1K 0.34% 77
2020
Q4
$1.16M Buy
3,427
+119
+4% +$40.1K 0.27% 111
2020
Q3
$888K Buy
3,308
+187
+6% +$50.2K 0.24% 122
2020
Q2
$821K Buy
3,121
+600
+24% +$158K 0.24% 123
2020
Q1
$572K Buy
2,521
+60
+2% +$13.6K 0.22% 131
2019
Q4
$743K Buy
2,461
+1,068
+77% +$322K 0.26% 124
2019
Q3
$334K Sell
1,393
-907
-39% -$217K 0.12% 179
2019
Q2
$649K Sell
2,300
-1,239
-35% -$350K 0.24% 123
2019
Q1
$1.02M Buy
3,539
+6
+0.2% +$1.72K 0.37% 81
2018
Q4
$928K Buy
3,533
+114
+3% +$29.9K 0.37% 76
2018
Q3
$937K Sell
3,419
-393
-10% -$108K 0.34% 82
2018
Q2
$907K Buy
+3,812
New +$907K 0.32% 88
2016
Q4
Sell
-325
Closed -$40K 671
2016
Q3
$40K Hold
325
0.02% 276
2016
Q2
$43K Buy
+325
New +$43K 0.02% 263